STATERA BIOPHARMA Trademark

Trademark Overview


On Wednesday, September 1, 2021, a trademark application was filed for STATERA BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the STATERA BIOPHARMA trademark a serial number of 97007302. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Sunday, March 16, 2025. This trademark is owned by Statera Biopharma, Inc.. The STATERA BIOPHARMA trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral ...

Medical and pharmaceutical research services; pharmaceutical research and development
statera biopharma

General Information


Serial Number97007302
Word MarkSTATERA BIOPHARMA
Filing DateWednesday, September 1, 2021
Status645 - FINAL REFUSAL - MAILED
Status DateSunday, March 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesEducational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields
Goods and ServicesPharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements
Goods and ServicesMedical and pharmaceutical research services; pharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameStatera Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Collins, CO 80526

Trademark Events


Event DateEvent Description
Saturday, September 4, 2021NEW APPLICATION ENTERED
Thursday, October 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 12, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, January 15, 2022ASSIGNED TO LIE
Tuesday, January 18, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 6, 2022ASSIGNED TO EXAMINER
Sunday, June 12, 2022NON-FINAL ACTION WRITTEN
Sunday, June 12, 2022NON-FINAL ACTION E-MAILED
Sunday, June 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 14, 2023SUSPENSION LETTER WRITTEN
Saturday, January 14, 2023LETTER OF SUSPENSION E-MAILED
Saturday, January 14, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 18, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 19, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 2, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, March 16, 2025FINAL REFUSAL E-MAILED
Sunday, March 16, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, March 16, 2025FINAL REFUSAL WRITTEN